?Dabigatran versus warfarin in atrial fibrillation patients post catheter ablatio
Phase 2
- Conditions
- Atrial Fibrillation.Atrial fibrillation and flutter
- Registration Number
- IRCT2012122311855N1
- Lead Sponsor
- Tehran University of Medical Science
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
drug-refractory, symptomatic AF who had indications for ablation included in this study. Patients were excluded in the presence of a severe heart-valve disorder, stroke within 14 days or severe stroke within 6 months before screening, a condition that increased the risk of hemorrhage, a creatinine clearance of less than 30 ml per minute, an active liver disease, and pregnancy
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method CRP. Timepoint: baseline, first month, third month. Method of measurement: serum samples.;D-Dimer. Timepoint: baseline, first month, third month. Method of measurement: serum samples.;Prothrombin fragment F1+2. Timepoint: baseline, first month, third month. Method of measurement: serum samples.
- Secondary Outcome Measures
Name Time Method Bleeding. Timepoint: baseline, first month, third month. Method of measurement: CBC test.